Klabax

Clarithromycin, the active ingredient in Klabax, is a macrolide antibiotic presented as an oral tablet for systemic use. It treats a variety of bacterial infections, including respiratory, skin and gastrointestinal conditions, in both adult and pediatric patients as directed by a healthcare professional.

GNH USA supplies Klabax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Its network ensures timely delivery and regulatory compliance across EU and other markets.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections in the respiratory, sinus, bronchial, skin and gastrointestinal systems. - Community-acquired pneumonia: clears the causative bacteria to resolve lung infection. - Acute bacterial sinusitis: reduces sinus inflammation by eradicating pathogenic microbes. - Acute bacterial exacerbations of chronic bronchitis: improves airflow and reduces sputum production. - Skin and soft tissue infections: eliminates skin pathogens to promote healing. - Helicobacter pylori eradication: contributes to combination therapy for ulcer‑related infection.

Clarithromycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often occurring after dosing. - Diarrhea: loose stools that may be watery. - Abdominal pain: cramping or discomfort in the stomach area. - Altered taste: a temporary metallic or bitter sensation.

Serious or Rare Side Effects: - Clostridioides difficile-associated diarrhea: severe colitis requiring medical attention. - Hepatotoxicity: elevated liver enzymes or jaundice. - QT interval prolongation: risk of cardiac arrhythmias, especially with other QT‑prolonging agents.

Before prescribing clarithromycin, clinicians should consider several safety precautions. - Assess liver function: monitor hepatic enzymes prior to and during therapy. - Evaluate renal function: adjust use in severe renal impairment. - Review cardiac history: avoid in patients with known QT prolongation. - Check for macrolide allergy: discontinue if hypersensitivity reactions occur. - Store at ambient temperature: keep in original container, protect from moisture.

Clarithromycin interacts with several medicines, requiring careful management.

Major Interactions (Avoid): - Cisapride: may cause serious cardiac arrhythmias. - Ergot alkaloids: risk of ergotism and severe vasospasm. - Theophylline: increased plasma levels leading to toxicity. - Pimozide: heightened risk of QT prolongation.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, monitor INR. - Carbamazepine: reduced clarithromycin concentrations, may diminish efficacy. - Simvastatin: increased risk of myopathy, consider dose adjustment.